ClinicalTrials.gg
CompletedNCT06398912FunFreqNICUUpdated Aug 22, 2025

Studying Newborns' Brain Activity in the NICU Through a Musical Intervention: the Role of Fundamental Frequency

An interventional study of Music Based Intervention in Premature Birth, sponsored by Athens General Children's Hospital "Pan. & Aglaia Kyriakou". Completed at 1 site in Greece. Open to participants aged 28 Weeks to 32 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Athens General Children's Hospital "Pan. & Aglaia Kyriakou" · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Apr 2023, registered Apr 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
28 Weeks to 32 Weeks
Sex
All
01

Study summary

This research project stands to the intersection of neonatology, neuroscience, and music based interventions (MBIs), exploring the impact of structured sound on the brain activity of premature newborns in Neonatal Intensive Care Units (NICU). It embarks on a pioneering investigation to decipher how variations in musical stimuli, particularly those that differ in human profiles (gender and kinship) and fundamental frequencies, affect the short-term electroencephalographic (EEG) footprint of these vulnerable infants. The project aims to uncover profound insights into the therapeutic potential of music within neonatal care, thereby advancing our understanding of neurodevelopmental interventions for premature infants.

Read the detailed description

Research Design and Methodology

Adopting an exploratory/randomized control trial (RCT) design, this study is meticulously planned to evaluate the effects of musical interventions on premature infants housed within a NICU setting. Therefore, participants, specifically newborns born at ≤ 32 weeks of gestation who meet stringent inclusion criteria, are randomly assigned to either an intervention group that receives structured musical interventions for a week or a control group that does not receive any musical stimulation. This methodological approach ensures a controlled examination of the intervention's efficacy, attributing observed neurophysiological changes directly to the musical stimuli.

Data Collection Protocol

The data collection protocol employs a dual approach: quantitative EEG for capturing the infants' brain activity and qualitative video recordings to document the dynamic interactions between the infants and the music facilitators. This multifaceted strategy ensures a comprehensive analysis of the effects of musical interventions, facilitated by a diverse group of individuals including male and female music therapists, and the infants' parents. Such diversity allows for a nuanced exploration of how different human profiles influence the intervention's impact on brain activity patterns.

Tools for Data Collection

The primary instrument for data collection is an 6-channel EEG system, chosen for its precision in measuring the complex electrical dynamics of the infants' brains. This is complemented by a high definition video camera that aims to capture the qualitative dimensions of the intervention, such as the infants' behavioral responses and the nuanced interaction dynamics between the infant and the facilitator. Together, these tools promise a holistic dataset that bridges the gap between neurophysiological and behavioral observations.

Data Analysis Protocol

The data analysis framework is comprehensive, incorporating (tentatively) a Repeated Measures Analysis of Variance (ANOVA) to scrutinize brain activity across different conditions, facilitators and qEEG features. This is to dissect the EEG data across the available condition variables, identifying specific patterns and variations indicative of the musical stimuli's impact.

Significance and Expected Outcomes

By melding advanced methodological design with innovative data collection and analysis techniques, the project is uniquely positioned to elucidate the neurodevelopmental benefits of musical interventions for premature infants in the NICU environment.

02

Conditions studied

  • Premature Birth

Browse trials for

Keywords

  • Premature Infants
  • Music
  • Brain Development
  • Pediatrics
  • Neonatology
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's enrollment of 31 is below the median of 84 across 1,666 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Athens General Children's Hospital "Pan. & Aglaia Kyriakou" is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Born at (equal or less than) 32 weeks of gestation
  • Absence of auditory insufficiency in the 8th cranial nerve and excessive pathology in the brainstem
  • Negative bilateral "transient evoked otoacoustic emissions," indicating unresponsiveness of the inner ear to an acoustic stimulus.
  • Weighing 1000 grams or more
  • In stable health conditions with no imminent risk of death
  • Not sedated
  • Absence of neonatal sepsis.
  • No congenital, genetic, or chromosomal abnormalities.
  • No nuclear jaundice.
  • No maternal use of illicit drugs during pregnancy.
  • No necessity for mechanical ventilation that creates excessive noise (i.e., high-frequency oscillatory ventilation).
  • No need for sedative drug administration to the neonate.
  • Absence of endocrine disorders (e.g., congenital hypothyroidism).

Exclusion criteria

Exclusion Criteria:

  • If a newborn is diagnosed with a disease or dysfunction during the study and the medical staff recommends their removal, they will be automatically excluded from the recruited sample.
  • Use of other music stimulation during the implementation of the intervention period
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Music Intervention

    Participants will be exposed to an organized sound stimulus (music) during the EEG measurement

    Other: Music Based Intervention

  • No intervention
    Control Group

    Participants will not be exposed to an organized sound stimulus at any point of the EEG measurement

Interventions

  • OtherMusic Based Intervention

    Measuring how the fundamental frequency of differential music facilitators (mother, father, male and female music therapist) impacts the premature infant brain

    Also known as: Fundamental Frequency and Brain Development Intervention

06

What researchers measure

Primary outcomes

  1. qEEG features changes before, during and after the delivery of the musical intervention correlated to the fundamental frequency of the signing voice of the music facilitators

    a predefined set of qEEG features (rEEG, coherence, spectral power etc) will be measured and analyzed via a 6 channels EEG unit in the NICU,

    Time frame: up to 18 months

07

Study locations

1 site
  • Panagiotis and Aglaia Kyriakou Childrens Hospital
    Athens, Greece
08

References and documents

Publications

  • Papatzikis E, Dimitropoulos K, Tataropoulou K, Kyrtsoudi M, Pasoudi E, O'Toole JM, Nika A. The father's singing voice may impact premature infants' brain more than their mother's: A NICU single-arm exploratory study protocol and preliminary data on a singing and EEG framework based on the fundamental frequency of voice and kinship. PLoS One. 2025 Aug 14;20(8):e0328211. doi: 10.1371/journal.pone.0328211. eCollection 2025. PubMed 40811513 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2023 to primary completion in Jul 2025, 27 months.

Of 741 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 27 months is above that.

Counting every sponsor, half of 759 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2024
First posted
May 3, 2024
StartActual
Apr 20, 2023
Primary completionActual
Jul 30, 2025
CompletionActual
Jul 30, 2025
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06398912
Lead sponsor
Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Responsible party
Dr Angeliki Nika (Neonatologist - Director of NICU, Athens General Children's Hospital "Pan. & Aglaia Kyriakou") — Principal investigator
First posted
May 3, 2024
Start date
Apr 20, 2023
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025
Last update
Aug 22, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion